DIFFERENTIAL GENE REGULATION IN NORMAL & TRANSFORMED KERATINOCYTES BY 1,25(OH)2
DIFFERENTIAL GENE REGULATION IN NORMAL & TRANSFORMED KERATINOCYTES BY 1,25(OH)2
批准号:
8169729
负责人:
DANIEL David BIKLE
金额:
$0.35万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-12 至 2011-05-31
关键词:
AcidsBindingCell LineComplexComputer Retrieval of Information on Scientific Projects DatabaseDNA SequenceFundingGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGrantHumanInstitutionLigandsLinkMalignant Epithelial CellMalignant NeoplasmsMediatingNuclear ExtractNuclear Hormone ReceptorsPreventionProteinsRNA Polymerase IIRXRRecruitment ActivityResearchResearch PersonnelResourcesResponse ElementsSourceSquamous cell carcinomaSteroid ReceptorsThyroid GlandTranscription InitiationTretinoinUndifferentiatedUnited States National Institutes of HealthVDR interacting protein complex DRIPVitamin AVitamin DVitamin D Response Elementcofactorhormone response elementhuman RIPK1 proteinkeratinocytekeratinocyte differentiationpromoterreceptorreceptor bindingresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The active metabolites of vitamin D and vitamin A show promise in the prevention and treatment of a number of malignancies including squamous cell carcinoma (SCC). 1,25(OH)2D regulates gene expression through its nuclear hormone receptor VDR. VDR partners with the retinoic X (RXR) and retinoic acid (RAR) receptors which bind the active metabolites of vitamin A, 9cis retinoic acid (9cisRA) and all trans retinoic acid (tRA), respectively. VDR, RXR, and RAR form heterodimers, which stimulate gene expression through specific sequences of DNA in the promoter of genes called hormone response elements. Different vitamin D responsive genes have different response elements and are differentially regulated by 1,25(OH)2D and RA in normal human keratinocytes (NHK). Squamous carcinoma cell lines (SCC) fail to respond to 1,25(OH)2D or RA in the same manner as NHK. The SCC lines we have studied have normal levels of VDR with normal binding of the VDR to its ligand and normal binding of the VDR to the vitamin D response elements (VDRE). Therefore, the explanation for the loss of response of SCC to 1,25(OH)2D has been unclear. However, it has recently been discovered that nuclear hormone receptors such as VDR, RAR, and RXR interact with a number of coactivators and cosuppressors which link the nuclear hormone receptors bound to their respective response elements to the transcription initiation complex where transcription by RNA polymerase II begins. During the previous funding period we discovered that the principal binding complex to VDR in nuclear extracts from undifferentiated normal keratinocytes is DRIP (vitamin D receptor interacting protein), a complex essentially identical to TRAP (thyroid receptor activating protein) and ARC (activator-recruited cofactor) which were identified by their binding to other nuclear hormone receptors. During normal keratinocyte differentiation DRIP is downregulated. Its binding to VDR is replaced by two SRC (steroid receptor coactivator). More recently we found that hairless acts as a suppressor of VDR action. We are currently involved in determining the factors that mediate this suppressor action of hairless on VDR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BCCMA:Foundational Research to Act Upon and Resist Conditions unfavorable to bone (FRACTURECURB):Role of abaloparatide for fracture healing
-
批准号:10584445
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:DANIEL David BIKLE
-
依托单位:
Vitamin D and Calcium signaling in epidermal stem cell maintenance, activation, and function
-
批准号:10265328
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:DANIEL David BIKLE
-
依托单位:
Mechanisms Underlying Hormonal Regulation of Fracture Repair
-
批准号:8598072
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DANIEL David BIKLE
-
依托单位:
Mechanisms Underlying Hormonal Regulation of Fracture Repair
-
批准号:8246977
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DANIEL David BIKLE
-
依托单位:
Mechanisms Underlying Hormonal Regulation of Fracture Repair
-
批准号:8413380
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DANIEL David BIKLE
-
依托单位:
Role of vitamin D and calcium signaling in wound healing
-
批准号:8140652
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:DANIEL David BIKLE
-
依托单位:
Role of vitamin D and calcium signaling in wound healing
-
批准号:8696816
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:DANIEL David BIKLE
-
依托单位:
Role of vitamin D and calcium signaling in wound healing
-
批准号:8398958
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:DANIEL David BIKLE
-
依托单位:
Role of vitamin D and calcium signaling in wound healing
-
批准号:8257062
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:DANIEL David BIKLE
-
依托单位:
DIFFERENTIAL GENE REGULATION IN NORMAL & TRANSFORMED KERATINOCYTES BY 1,25(OH)2
-
批准号:8363736
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2011
-
负责人:DANIEL David BIKLE
-
依托单位:
Vitamin D Receptor Coactivators in Keratinocytes
-
批准号:7834026
-
项目类别:
-
资助金额:$37.19万
-
财政年份:2009
-
负责人:DANIEL David BIKLE
-
依托单位:
Role of IGF-I/integrin signaling in the periosteal response to load
-
批准号:9211290
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2008
-
负责人:DANIEL David BIKLE
-
依托单位:
Role of IGF-I/integrin signaling in the periosteal response to load
-
批准号:9020926
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2008
-
负责人:DANIEL David BIKLE
-
依托单位:
Integrin Regulation of IGF-1 Responsiveness in Bone During Mechanical Loading
-
批准号:7580342
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2008
-
负责人:DANIEL David BIKLE
-
依托单位:
Role of IGF-I/integrin signaling in the periosteal response to load
-
批准号:8886593
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2008
-
负责人:DANIEL David BIKLE
-
依托单位:
Integrin Regulation of IGF-1 Responsiveness in Bone During Mechanical Loading
-
批准号:8315908
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2008
-
负责人:DANIEL David BIKLE
-
依托单位:
Integrin Regulation of IGF-1 Responsiveness in Bone During Mechanical Loading
-
批准号:8121549
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2008
-
负责人:DANIEL David BIKLE
-
依托单位:
Integrin Regulation of IGF-1 Responsiveness in Bone During Mechanical Loading
-
批准号:7915522
-
项目类别:
-
资助金额:$33.76万
-
财政年份:2008
-
负责人:DANIEL David BIKLE
-
依托单位:
Integrin Regulation of IGF-1 Responsiveness in Bone During Mechanical Loading
-
批准号:7690852
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2008
-
负责人:DANIEL David BIKLE
-
依托单位:
Role of IGF-I/integrin signaling in the periosteal response to load
-
批准号:9423436
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2008
-
负责人:DANIEL David BIKLE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: